Home » Topics » Drug design, drug delivery and technologies, BioWorld Science

Drug design, drug delivery and technologies, BioWorld Science
RSS

Engineered virus-like particles for in vivo delivery of gene editing proteins

Jan. 24, 2022

Subcutaneous nanocarrier-mediated delivery of rapamycin

Jan. 19, 2022

4basebio and eTheRNA collaborate to evaluate linear DNA for mRNA production

Jan. 18, 2022

PostEra and Pfizer expand strategic collaboration

Jan. 12, 2022

Methamphetamine harnessed for good in BBB transport

Jan. 12, 2022

Amgen and Arrakis collaborate to discover and develop targeted RNA degrader therapeutics

Jan. 12, 2022

Pfizer and Codex DNA collaborate to leverage EDS technology for mRNA-based vaccines

Jan. 11, 2022

Pfizer and Beam Therapeutics collaborate to advance in vivo base editing programs

Jan. 10, 2022

Bayer and Mammoth Biosciences enter collaboration and option agreement on Mammoth's CRISPR systems

Jan. 10, 2022

Ideaya acquires INQUIRE chemical library

Jan. 5, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
Europe’s Alzecure, Orionis in $1B+ deals with Lilly, Novartis
BioWorld
Two companies with European ties signed billion-dollar deals with large pharma firms in the last two days to discover and develop molecular glue drugs, as well as...
Sanofi phase III CIDP quit dents Dianthus; C1 mismatch?
BioWorld
Investors in Dianthus Therapeutics Inc. apparently chose to ignore subtleties in the difference between efforts with that firm’s claseprubart vs. those by...
Microbiota modulates the antidepressant effects of GLP-1 analogues
BioWorld Science
Liraglutide, a glucagon-like peptide 1 (GLP-1) receptor agonist used in diabetes and obesity, could alleviate depression through a pathway that does not depend on...